During placebo infusion, glucagon levels were significantly higher in patients with diabetes compared with healthy lean individuals (p = 0.004), with levels being increased by exendin 9-39 compared with placebo (p = 0.004 and p < 0.001, respectively). Here, GCG is linked to diabetes mellitus.